167 related articles for article (PubMed ID: 26702071)
1. Renal iron overload in rats with diabetic nephropathy.
Dominguez JH; Liu Y; Kelly KJ
Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26702071
[TBL] [Abstract][Full Text] [Related]
2. Renal C3 complement component: feed forward to diabetic kidney disease.
Kelly KJ; Liu Y; Zhang J; Dominguez JH
Am J Nephrol; 2015; 41(1):48-56. PubMed ID: 25662584
[TBL] [Abstract][Full Text] [Related]
3. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy.
Kelly KJ; Burford JL; Dominguez JH
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F923-31. PubMed ID: 19656916
[TBL] [Abstract][Full Text] [Related]
4. Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy.
Kelly KJ; Zhang J; Han L; Wang M; Zhang S; Dominguez JH
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1804-12. PubMed ID: 24133118
[TBL] [Abstract][Full Text] [Related]
5. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload.
Chaudhary K; Chilakala A; Ananth S; Mandala A; Veeranan-Karmegam R; Powell FL; Ganapathy V; Gnana-Prakasam JP
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F512-F517. PubMed ID: 31188032
[TBL] [Abstract][Full Text] [Related]
6. Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats.
Tofovic SP; Kusaka H; Kost CK; Bastacky S
Ren Fail; 2000; 22(4):387-406. PubMed ID: 10901178
[TBL] [Abstract][Full Text] [Related]
7. Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
Kubota M; Watanabe R; Yamaguchi M; Hosojima M; Saito A; Fujii M; Fujimura S; Kadowaki M
Br J Nutr; 2016 Oct; 116(8):1326-1335. PubMed ID: 27724997
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.
Kelly KJ; Liu Y; Zhang J; Goswami C; Lin H; Dominguez JH
Physiol Genomics; 2013 Aug; 45(16):710-9. PubMed ID: 23757392
[TBL] [Abstract][Full Text] [Related]
9. Evaluating renal iron overload in diabetes mellitus by blood oxygen level-dependent magnetic resonance imaging: a longitudinal experimental study.
Geng W; Pan L; Shen L; Sha Y; Sun J; Yu S; Qiu J; Xing W
BMC Med Imaging; 2022 Nov; 22(1):200. PubMed ID: 36401188
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy.
Kelly KJ; Dominguez JH
Nephrol Dial Transplant; 2010 Oct; 25(10):3204-12. PubMed ID: 20466672
[TBL] [Abstract][Full Text] [Related]
11. Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.
Dominguez J; Wu P; Packer CS; Temm C; Kelly KJ
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F670-9. PubMed ID: 17596532
[TBL] [Abstract][Full Text] [Related]
12. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
14. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations.
Dominguez JH; Mehta JL; Li D; Wu P; Kelly KJ; Packer CS; Temm C; Goss E; Cheng L; Zhang S; Patterson CE; Hawes JW; Peterson R
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F110-9. PubMed ID: 17989113
[TBL] [Abstract][Full Text] [Related]
15. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Togashi Y; Miyamoto Y
Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
18. Iron increases diabetes-induced kidney injury and oxidative stress in rats.
Gao W; Li X; Gao Z; Li H
Biol Trace Elem Res; 2014 Sep; 160(3):368-75. PubMed ID: 24996958
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal iron accumulation in diabetic nephropathy.
Nankivell BJ; Tay YC; Boadle RA; Harris DC
Ren Fail; 1994; 16(3):367-81. PubMed ID: 8059020
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.
Shukla R; Banerjee S; Tripathi YB
BMC Complement Altern Med; 2018 May; 18(1):156. PubMed ID: 29751837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
